breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 40 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 4,612,067 | 0 | A | G | 66.7% | ‑5.4 / 16.7 | 27 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
* | NZ_CP009273 | 2,141,214 | 0 | T | G | 62.5% | 5.7 / 12.0 | 16 | G20G (GGT→GGG) | yegD | molecular chaperone |
* | NZ_CP009273 | 353,601 | 0 | C | A | 58.8% | ‑1.3 / 17.8 | 17 | L267F (TTG→TTT) | cynR | transcriptional regulator CynR |
* | NZ_CP009273 | 3,273,830 | 0 | A | C | 58.8% | 11.8 / 16.4 | 17 | T85T (ACA→ACC) | agaV | PTS N‑acetylgalactosamine transporter subunit IIB |
* | NZ_CP009273 | 2,852,466 | 0 | T | G | 58.3% | 1.4 / 17.3 | 24 | V672G (GTG→GGG) | mutS | DNA mismatch repair protein MutS |
* | NZ_CP009273 | 510,080 | 0 | A | C | 57.1% | 6.2 / 12.6 | 14 | V79G (GTG→GGG) | ybbJ | NfeD family protein |
* | NZ_CP009273 | 4,186,009 | 0 | T | G | 57.1% | 6.9 / 11.1 | 14 | T7P (ACC→CCC) | thiC | phosphomethylpyrimidine synthase ThiC |
* | NZ_CP009273 | 765,675 | 0 | A | C | 56.2% | 12.2 / 17.0 | 17 | T748P (ACC→CCC) | mngB | mannosylglycerate hydrolase |
* | NZ_CP009273 | 976,689 | 0 | A | G | 56.2% | ‑0.9 / 11.8 | 16 | I63V (ATC→GTC) | ldtD | L,D‑transpeptidase |
* | NZ_CP009273 | 3,549,564 | 0 | A | C | 56.0% | 12.5 / 27.8 | 25 | S215R (AGT→AGG) ‡ | rtcA | RNA 3'‑terminal phosphate cyclase |
* | NZ_CP009273 | 3,549,566 | 0 | T | C | 56.0% | 7.5 / 30.0 | 25 | S215G (AGT→GGT) ‡ | rtcA | RNA 3'‑terminal phosphate cyclase |
* | NZ_CP009273 | 1,906,011 | 0 | T | G | 53.8% | 8.9 / 14.3 | 13 | T275P (ACC→CCC) | htpX | protease HtpX |
* | NZ_CP009273 | 4,527,926 | 0 | A | C | 53.8% | 3.5 / 10.9 | 13 | G219G (GGT→GGG) | nanM | N‑acetylneuraminate epimerase |
* | NZ_CP009273 | 510,067 | 0 | C | T | 53.3% | 0.9 / 16.2 | 15 | K83K (AAG→AAA) | ybbJ | NfeD family protein |
* | NZ_CP009273 | 822,955 | 0 | T | G | 53.3% | 6.4 / 13.5 | 15 | T495P (ACC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
* | NZ_CP009273 | 822,963 | 0 | T | G | 53.3% | ‑0.4 / 14.6 | 15 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |
* | NZ_CP009273 | 3,436,636 | 0 | A | C | 53.3% | 1.9 / 16.6 | 15 | V274G (GTA→GGA) | secY | preprotein translocase subunit SecY |
* | NZ_CP009273 | 4,594,161 | 0 | C | T | 53.1% | 7.9 / 39.2 | 32 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
* | NZ_CP009273 | 429,105 | 0 | T | G | 52.9% | 4.5 / 11.1 | 17 | G65G (GGT→GGG) | ribD | bifunctional diaminohydroxyphosphoribosylaminopyrimidine deaminase/5‑amino‑6‑(5‑phosphoribosylamino)uracil reductase RibD |
* | NZ_CP009273 | 883,470 | 0 | T | G | 52.9% | 16.1 / 20.2 | 17 | intergenic (+55/+120) | rcdA/ybjL | DNA‑binding transcriptional regulator RcdA/aspartate:alanine antiporter |